Impact of Endotest on Patients' Quality of Life: a Cohort Study
NCT07560852
· ctgov
recruiting
- Enrollment
- 20,000
- Start
- 2026-05-06
- Completion
- 2029-07-31
- Last updated
- 2026-05-26
- Has results
- False
- Countries
- France
Conditions
Tagged with
Interventions
-
Questionnaire
OTHER
EHP 5+6, RAND-36 et 6 and 12 months follow-up visits
Eligibility criteria
Inclusion Criteria:
* Women with a prescription for Endotest
* Women aged 18 to 43
* Who have dated and signed the consent form
* Affiliated with the French healthcare system or covered by health insurance abroad
Exclusion Criteria:
* Contraindications for the use of Endotest:
1. Current pregnancy;
2. Medical history of cancer or HIV infection;
3. Active infection at the time of saliva collection;
* Significant difficulty reading and understanding the language of the country in which the participant is located.
License: public-domain-us
· commercial use OK
· attribution required
Courtesy of ClinicalTrials.gov / U.S. National Library of Medicine
Courtesy of ClinicalTrials.gov / U.S. National Library of Medicine